They also demonstrate that the deletion of Usp22 in the MMTV-NIC mouse model resulted in a dramatic decrease in tumor burden and an increase in mice survival through the downregulation of the MMTV promoter that drives ERBB2/NEU oncogene expression. Here, USP22 is linked to neoplasm.